Testagen
Preclinical ResearchTestagen (Lys-Glu-Asp-Gly)
A Khavinson bioregulator tetrapeptide studied for testicular tissue function and reproductive hormone regulation.
Dose
0.1 mg
Route
Subcutaneous injection
Cycle
10 days
Storage
2°C to 8°C (refrigerator)
What is Testagen?
Testagen is a synthetic tetrapeptide, an artificial analogue of endogenous regulatory peptides. It belongs to the class of Khavinson bioregulators, which are short peptides (2-4 amino acids) hypothesized to regulate gene expression and protein synthesis in a tissue-specific manner. Specifically, Testagen (Ala-Glu-Asp-Gly) is derived from peptides isolated from mammalian testicular tissue. Research, primarily in animal models and in vitro, investigates its potential role in regulating testicular function and male reproductive health.
Key Benefits
- Testicular tissue research
🐾 Griffin Says...
Molecular Information
Molecular weight
429.5 g/mol
Length
4 amino acids
Type
Khavinson Bioregulator (tetrapeptide)
Amino acid sequence
Ala-Glu-Asp-Gly
Testagen is a synthetic tetrapeptide corresponding to a sequence found in peptides extracted from testicular tissue.
Research Indications
Testicular Tissue Function
Animal studies (e.g., rodents, primates) suggest Testagen may influence various parameters associated with testicular function, including spermatogenesis and hormone production. Evidence is primarily from preclinical models (animal/in-vitro only).
Hormone Regulation
Some preclinical research indicates Testagen may exert modulatory effects on reproductive hormones like testosterone, LH, and FSH levels in animal models. The exact mechanisms and extent of these effects require further elucidation (animal/in-vitro only).
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Investigate effects on testicular histology in healthy models | 0.1 mg | Once daily for 10 days | Subcutaneous injection |
| Assess impact on reproductive hormone profiles in aged animal models | 0.1 mg | Once daily for 10 days, repeated every 4-6 months | Subcutaneous injection |
| Study influence on spermatogenesis in rodent models | 0.05-0.1 mg | Once daily for 10 days | Subcutaneous injection |
| Examine gene expression related to testicular function in vitro | Variable, dependent on cell culture setup | Single or repeated application | In vitro (direct to cell culture medium) |
The typical protocol involves daily administration for 10 days, followed by an extended break.
Peptide Interactions
- Monitor Combination
Other Bioregulators
The Khavinson approach often involves combining several bioregulators. While theoretically compatible, specific combinations with Testagen require individual research for synergistic or antagonistic effects.
- Use Caution
Exogenous Hormones (e.g., Testosterone)
Due to its potential to modulate endogenous hormone production, combining Testagen with exogenous hormones may lead to unpredictable or exaggerated effects on the endocrine system. Monitor closely.
- Use Caution
GnRH Analogues
Peptides affecting the HPG axis, such as GnRH analogues, could interact with Testagen's proposed regulatory mechanisms. Concurrent use should be carefully considered and monitored in research settings.
- Compatible
Supplements for Male Health (e.g., Zinc, Vitamin D)
Generally considered compatible, as these supplements address nutritional deficiencies or support physiological processes indirectly. No known direct adverse interactions reported.
How to Reconstitute
- 1Gather materials: Testagen vial, bacteriostatic water for injection, sterile syringe with needle, alcohol wipes.
- 2Clean the rubber stopper of the Testagen vial and the bacteriostatic water vial with alcohol wipes.
- 3Draw the desired amount of bacteriostatic water (e.g., 1-2 mL) into the syringe.
- 4Slowly inject the bacteriostatic water into the Testagen vial, aiming for the side of the vial, not directly onto the powder.
- 5Gently swirl the vial (do not shake) until the lyophilized powder is completely dissolved. This may take a few minutes.
- 6Visually inspect the solution for any particulate matter or discoloration before use. The solution should be clear and colorless.
Always reconstitute with bacteriostatic water. Avoid vigorous shaking; gently swirl the vial to dissolve the powder completely.
What to Expect
- No immediate subjective sensation or 'rush' upon administration, typical for bioregulators.
- Local injection site reactions such as mild redness, itching, or swelling are possible but usually transient.
- Potential for long-term, subtle modulatory effects on testicular tissue function, as observed in animal studies.
- Consistent administration as per protocol is crucial, as effects are thought to be cumulative over the cycle.
- Effects, if any, are generally observed weeks to months after a cycle's completion, reflecting a regulatory rather than immediate stimulatory action.
- Individual responses may vary significantly due to biological variability.
Side Effects & Safety
- Research is primarily preclinical (animal/in vitro). Human safety data for this compound is very limited.
- Always use sterile practices for reconstitution and administration to prevent infection.
- Consult peer-reviewed literature and institutional review board guidelines before initiating any research involving novel peptides.
- Not intended for human consumption or therapeutic use. For research purposes only.
- Potential for immune response or allergic reactions, though rare with short peptides, cannot be entirely excluded.
- Proper disposal of sharps (needles, syringes) in a designated sharps container is essential.
Ready to calculate your dose? Use Griffin's Peptide Calculator 🐾
Open CalculatorPeptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.